Annual Drug Patent Expirations for STARLIX
Starlix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has forty-two patent family members in thirty countries.
Copyright © DrugPatentWatch. Originally published at Patent delisted for Novartis drug STARLIX